Ruxolitinib Plus Siremadlin Yielded Superior Spleen Volume Reduction in Patients With Myelofibrosis

Source: Pharmacy Times articles

The combination demonstrated improved efficacy compared with ruxolitinib as a monotherapy.
Read More

You must be logged in to post a comment.